Allworth Financial’s Pulmonx LUNG Stock Holding History

Allworth Financial’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$634	Buy	491 +472	+2,484%	+$780	﹤0.01%	4686
2025 Q4	$42	Buy	+19	New	+$36	﹤0.01%	4855

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allworth Financial's LUNG Position: Q1 2026 in Review

Allworth Financial increased its Pulmonx (LUNG) stake by 2,484% in Q1 2026, buying an estimated $780 and bringing the position to 491 shares worth $634. The position accounts for ﹤0.01% of the portfolio, ranked #4686.

Allworth Financial first reported a position in LUNG in Q4 2025 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

Allworth Financial held 491 shares of Pulmonx worth $634 as of Q1 2026.
Allworth Financial bought 472 Pulmonx shares in Q1 2026, an estimated $780.
Pulmonx made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4686 holding.
Allworth Financial first reported a position in Pulmonx in Q4 2025 and has held it in 2 quarters since.
113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.